Skip to main content
logo
Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
0.7943
0.00 (0.00%)
At close: Sep 4, 2026, 4:00 PM EDT
0.8100
+0.0157 (1.98%)
Pre-market: Sep 8, 2026, 7:00 AM EDT

Aprea Therapeutics Revenue

Aprea Therapeutics had revenue of $5.19K in the twelve months ending June 30, 2026, down -99.38% year-over-year. In the year 2025, Aprea Therapeutics had annual revenue of $285.76K, down -80.98%.

Revenue (ttm)
$5.19K
Revenue Growth
-99.38%
P/S Ratio
1,928.86
Revenue / Employee
$648
Employees
8
Market Cap
10.00M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025285.76K-1.22M-80.98%
Dec 31, 20241.50M919.35K157.63%
Dec 31, 2023583.23K--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Immuron5.34M
Ensysce Biosciences4.50M
Xenetic Biosciences3.26M
Vistagen Therapeutics2.50M
Daré Bioscience1.37M
CytoMed Therapeutics669.28K
Senti Biosciences Holdings55.00K
Azitra7.50K
Revenue Rankings

APRE News

More News